Chinese Professional Liquid Injection - Artemether+ lumefantrine tabs – KeMing Medicines Detail:
FOB Price | Inquiry |
Min.Order Quantity | 1,000,000 tablets |
Supply Ability | 120,000,000 tablets/Month |
Port | Shanghai |
Payment Terms | T/T in advance |
Product Detail | |
Product name | Artemether+ lumefantrine tabs |
Specification | 20+120mg |
Description | A yellow Tablet |
Standard | Factory Standard |
Package | 24’s/blister |
Transportation | Ocean,Land,Air |
Certificate | GMP |
Price | Inquiry |
Quality guaranteeperiod | for 36 months |
Product Description | [Indication] This drug is an antimalarial: it inhibits the reproduction of the parasite responsible for malaria. It combines two substances that have a complementary mode of action and duration of action. It is used in the curative treatment of malaria. schema: a first dose at the time of diagnosis, then taken at least 8 hours, 24.36, 48 hours and 60 hours after the first dose. |
Product detail pictures:
Related Product Guide:
Disease, Doctors, Drugs and Vitamins!
Drugs, Vitamins, Pills, Pills, Pills
With dependable high quality approach, great reputation and excellent customer support, the series of products and solutions produced by our firm are exported to lots of countries and regions for Chinese Professional Liquid Injection - Artemether+ lumefantrine tabs – KeMing Medicines, The product will supply to all over the world, such as: Rio de Janeiro, Zurich, Rio de Janeiro, we always keep our credit and mutual benefit to our client, insist our high quality service to moving our clients. always welcome the our friends and clients to come and visit our company and guid our business, if you are interested in our products, you can also submit your purchase information online, and we will contact you immediately, we keep our highly sincere cooperation and wish everything in your side are all well.
By Alberta from Liberia - 2017.05.21 12:31
Superb technology, perfect after-sales service and efficient work efficiency, we think this is our best choice.
By Dominic from Rome - 2017.07.28 15:46